Sprycel - About Hypertension

(Reuters) - Health regulators warned on Tuesday that Bristol-Myers Squibb Co's leukemia drug Sprycel may raise the risk of a rare, but serious condition characterized by abnormally high blood pressure in the arteries of the lungs.The condition, known as pulmonary arterial hypertension ...